This study is a Randomized Controlled clinical trial designed to compare the effectiveness of Triamcinolone acetonide and Amlexanox oral mucosal paste as adjuncts to oral dispersible Ketorolac Tromethamine for control of postoperative pain and enhancement of wound healing following Maxillary labial frenectomy performed using radiofrequency electrocautery. Postoperative pain and delayed healing are common concerns after Frenectomy procedure using Radiofrequency electrocautery and may affect patient compliance and satisfaction. Although Ketorolac Tromethamine provide systemic analgesic action topical adjuncts offer localized protective barrier and targeted anti inflammatory action at the surgical site thereby reducing the need for increased systemic dosing.

A total of twenty patients indicated for maxillary labial frenectomy will be randomly allocated into two groups in a 1 to 1 ratio. All participants will receive oral dispersible ketorolac tromethamine for postoperative analgesia. In addition Group A will receive topical triamcinolone acetonide oral mucosal paste and Group B will receive topical amlexanox oral mucosal paste applied over the sutured tissue surface as per protocol.

The primary outcome measure will be postoperative pain assessed using a visual analogue scale at predetermined time intervals. Secondary outcome measures will include clinical evaluation of oedema erythema and wound healing using a standardized healing index.

The study aims to determine which topical agent provides superior pain control and improved healing when used as an adjunct to standard analgesic therapy following frenectomy. The findings may help guide clinicians in selecting an effective postoperative management protocol with reduced systemic dosing of analgesic for patients undergoing maxillary labial frenectomy using radiofrequency electrocautery.